サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1096117

世界のヒト細胞性血管(HAV)市場：考察と予測 (2028年まで)

Global Human Acellular Vessels (HAVs) Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 111 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
世界のヒト細胞性血管(HAV)市場：考察と予測 (2028年まで)
出版日: 2022年07月04日
発行: QYResearch
ページ情報: 英文 111 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ヒト細胞性血管(HAV) (Human Acellular Vessels (HAVs)) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • ヒト細胞性血管(HAV)の製品概要
  • 市場：タイプ別
    • 世界のヒト細胞性血管(HAV)の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • ePTFE Vascular Graft
    • Polyester Vascular Graft
    • PTFE Vascular Graft
    • Others
  • 市場：アプリケーション別
    • 世界のヒト細胞性血管(HAV)の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Cardiovascular Diseases
    • Aneurysm
    • Vascular Occlusion
    • Others
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のヒト細胞性血管(HAV)の販売 推定および予測 2017-2028
  • 世界のヒト細胞性血管(HAV)の収益 推定および予測 2017-2028
  • 世界のヒト細胞性血管(HAV)の収益：地域別: 2017 VS 2021 VS 2028
  • 世界のヒト細胞性血管(HAV)の販売：地域別
    • 世界のヒト細胞性血管(HAV)の販売：地域別 (2017-2022)
    • 世界の販売 ヒト細胞性血管(HAV) ：地域別 (2023-2028)
  • 世界のヒト細胞性血管(HAV)の収益：地域別
    • 世界のヒト細胞性血管(HAV)の収益：地域別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界のヒト細胞性血管(HAV)の販売：メーカー別
    • 世界のヒト細胞性血管(HAV)の上位メーカー：販売別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： ヒト細胞性血管(HAV)2021
  • 世界のヒト細胞性血管(HAV)の収益：メーカー別
    • 世界のヒト細胞性血管(HAV)の収益：メーカー別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： ヒト細胞性血管(HAV)の収益 2021
  • 世界のヒト細胞性血管(HAV)の販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のヒト細胞性血管(HAV)の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のヒト細胞性血管(HAV)のメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界のヒト細胞性血管(HAV)の販売：タイプ別
    • 世界のヒト細胞性血管(HAV)の販売実績：タイプ別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の販売予測：タイプ別 (2023-2028)
    • 世界のヒト細胞性血管(HAV)の販売市場シェア：タイプ別 (2017-2028)
  • 世界のヒト細胞性血管(HAV)の収益：タイプ別
    • 世界のヒト細胞性血管(HAV)の収益実績：タイプ別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の収益予測：タイプ別 (2023-2028)
    • 世界のヒト細胞性血管(HAV)の収益市場シェア：タイプ別 (2017-2028)
  • 世界のヒト細胞性血管(HAV)の価格：タイプ別
    • 世界のヒト細胞性血管(HAV)の価格：タイプ別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界のヒト細胞性血管(HAV)の販売：アプリケーション別
    • 世界のヒト細胞性血管(HAV)の販売実績：アプリケーション別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の販売予測：アプリケーション別 (2023-2028)
    • 世界のヒト細胞性血管(HAV)の販売市場シェア：アプリケーション別 (2017-2028)
  • 世界のヒト細胞性血管(HAV)の収益：アプリケーション別
    • 世界のヒト細胞性血管(HAV)の収益実績：アプリケーション別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の収益予測：アプリケーション別 (2023-2028)
    • 世界のヒト細胞性血管(HAV)の収益市場シェア：アプリケーション別 (2017-2028)
  • 世界のヒト細胞性血管(HAV)の価格：アプリケーション別
    • 世界のヒト細胞性血管(HAV)の価格：アプリケーション別 (2017-2022)
    • 世界のヒト細胞性血管(HAV)の価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米のヒト細胞性血管(HAV) 市場規模：タイプ別
    • 北米のヒト細胞性血管(HAV)の販売：タイプ別 (2017-2028)
    • 北米のヒト細胞性血管(HAV)の収益：タイプ別 (2017-2028)
  • 北米のヒト細胞性血管(HAV) 市場規模：アプリケーション別
    • 北米のヒト細胞性血管(HAV)の販売：アプリケーション別 (2017-2028)
    • 北米のヒト細胞性血管(HAV)の収益：アプリケーション別 (2017-2028)
  • 北米のヒト細胞性血管(HAV) 市場規模：国別
    • 北米のヒト細胞性血管(HAV)の販売：国別 (2017-2028)
    • 北米のヒト細胞性血管(HAV)の収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のヒト細胞性血管(HAV) 市場規模：タイプ別
    • 欧州のヒト細胞性血管(HAV)の販売：タイプ別 (2017-2028)
    • 欧州のヒト細胞性血管(HAV)の収益：タイプ別 (2017-2028)
  • 欧州のヒト細胞性血管(HAV) 市場規模：アプリケーション別
    • 欧州のヒト細胞性血管(HAV)の販売：アプリケーション別 (2017-2028)
    • 欧州のヒト細胞性血管(HAV)の収益：アプリケーション別 (2017-2028)
  • 欧州のヒト細胞性血管(HAV) 市場規模：国別
    • 欧州のヒト細胞性血管(HAV)の販売：国別 (2017-2028)
    • 欧州のヒト細胞性血管(HAV)の収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のヒト細胞性血管(HAV) 市場規模：タイプ別
    • アジア太平洋のヒト細胞性血管(HAV)の販売：タイプ別 (2017-2028)
    • アジア太平洋のヒト細胞性血管(HAV)の収益：タイプ別 (2017-2028)
  • アジア太平洋のヒト細胞性血管(HAV) 市場規模：アプリケーション別
    • アジア太平洋のヒト細胞性血管(HAV)の販売：アプリケーション別 (2017-2028)
    • アジア太平洋のヒト細胞性血管(HAV)の収益：アプリケーション別 (2017-2028)
  • アジア太平洋のヒト細胞性血管(HAV) 市場規模：地域別
    • アジア太平洋のヒト細胞性血管(HAV)の販売：地域別 (2017-2028)
    • アジア太平洋のヒト細胞性血管(HAV)の収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア

第9章 ラテンアメリカ

  • ラテンアメリカのヒト細胞性血管(HAV) 市場規模：タイプ別
    • ラテンアメリカのヒト細胞性血管(HAV)の販売：タイプ別 (2017-2028)
    • ラテンアメリカのヒト細胞性血管(HAV)の収益：タイプ別 (2017-2028)
  • ラテンアメリカのヒト細胞性血管(HAV) 市場規模：アプリケーション別
    • ラテンアメリカのヒト細胞性血管(HAV)の販売：アプリケーション別 (2017-2028)
    • ラテンアメリカのヒト細胞性血管(HAV)の収益：アプリケーション別 (2017-2028)
  • ラテンアメリカのヒト細胞性血管(HAV) 市場規模：国別
    • ラテンアメリカのヒト細胞性血管(HAV)の販売：国別 (2017-2028)
    • ラテンアメリカのヒト細胞性血管(HAV)の収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカ

  • 中東・アフリカのヒト細胞性血管(HAV) 市場規模：タイプ別
    • 中東・アフリカのヒト細胞性血管(HAV)の販売：タイプ別 (2017-2028)
    • 中東・アフリカのヒト細胞性血管(HAV)の収益：タイプ別 (2017-2028)
  • 中東・アフリカのヒト細胞性血管(HAV) 市場規模：アプリケーション別
    • 中東・アフリカのヒト細胞性血管(HAV)の販売：アプリケーション別 (2017-2028)
    • 中東・アフリカのヒト細胞性血管(HAV)の収益：アプリケーション別 (2017-2028)
  • 中東・アフリカのヒト細胞性血管(HAV) 市場規模：国別
    • 中東・アフリカのヒト細胞性血管(HAV)の販売：国別 (2017-2028)
    • 中東・アフリカのヒト細胞性血管(HAV)の収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • Getinge Group
  • Bard
  • Terumo
  • W. L. Gore
  • JUNKEN MEDICAL
  • B.Braun
  • LeMaitre
  • Shanghai Suokang
  • Shanghai Chest Medical
  • Maquet
  • Wuhan Yangsen
  • Vascutek
  • Jotec Gmbh
  • InterVAscular
  • Atrium Medical

第12章 業界チェーンと販売チャネルの分析

  • ヒト細胞性血管(HAV) 業界チェーン分析
  • ヒト細胞性血管(HAV) 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • ヒト細胞性血管(HAV) 生産形態とプロセス
  • ヒト細胞性血管(HAV) 販売およびマーケティング
    • ヒト細胞性血管(HAV) 販売チャネル
    • ヒト細胞性血管(HAV) 卸業者
  • ヒト細胞性血管(HAV) 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • ヒト細胞性血管(HAV) 業界動向
  • ヒト細胞性血管(HAV) 市場の促進要因
  • ヒト細胞性血管(HAV) 市場の課題
  • ヒト細胞性血管(HAV) 市場の抑制要因

第14章 世界のヒト細胞性血管(HAV)の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Human Acellular Vessels (HAVs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of ePTFE Vascular Graft
  • Table 3. Major Manufacturers of Polyester Vascular Graft
  • Table 4. Major Manufacturers of PTFE Vascular Graft
  • Table 5. Major Manufacturers of Others
  • Table 6. Global Human Acellular Vessels (HAVs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Human Acellular Vessels (HAVs) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 8. Global Human Acellular Vessels (HAVs) Sales by Region (2017-2022) & (K Units)
  • Table 9. Global Human Acellular Vessels (HAVs) Sales Market Share by Region (2017-2022)
  • Table 10. Global Human Acellular Vessels (HAVs) Sales by Region (2023-2028) & (K Units)
  • Table 11. Global Human Acellular Vessels (HAVs) Sales Market Share by Region (2023-2028)
  • Table 12. Global Human Acellular Vessels (HAVs) Revenue by Region (2017-2022) & (US$ Million)
  • Table 13. Global Human Acellular Vessels (HAVs) Revenue Market Share by Region (2017-2022)
  • Table 14. Global Human Acellular Vessels (HAVs) Revenue by Region (2023-2028) & (US$ Million)
  • Table 15. Global Human Acellular Vessels (HAVs) Revenue Market Share by Region (2023-2028)
  • Table 16. Global Human Acellular Vessels (HAVs) Sales by Manufacturers (2017-2022) & (K Units)
  • Table 17. Global Human Acellular Vessels (HAVs) Sales Share by Manufacturers (2017-2022)
  • Table 18. Global Human Acellular Vessels (HAVs) Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 19. Global Human Acellular Vessels (HAVs) Revenue Share by Manufacturers (2017-2022)
  • Table 20. Human Acellular Vessels (HAVs) Price by Manufacturers (2017-2022) &(US$/Unit)
  • Table 21. Global Human Acellular Vessels (HAVs) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Human Acellular Vessels (HAVs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Acellular Vessels (HAVs) as of 2021)
  • Table 23. Human Acellular Vessels (HAVs) Manufacturing Base Distribution and Headquarters
  • Table 24. Manufacturers Human Acellular Vessels (HAVs) Product Offered
  • Table 25. Date of Manufacturers Enter into Human Acellular Vessels (HAVs) Market
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Human Acellular Vessels (HAVs) Sales by Type (2017-2022) & (K Units)
  • Table 28. Global Human Acellular Vessels (HAVs) Sales by Type (2023-2028) & (K Units)
  • Table 29. Global Human Acellular Vessels (HAVs) Sales Share by Type (2017-2022)
  • Table 30. Global Human Acellular Vessels (HAVs) Sales Share by Type (2023-2028)
  • Table 31. Global Human Acellular Vessels (HAVs) Revenue by Type (2017-2022) & (US$ Million)
  • Table 32. Global Human Acellular Vessels (HAVs) Revenue by Type (2023-2028) & (US$ Million)
  • Table 33. Global Human Acellular Vessels (HAVs) Revenue Share by Type (2017-2022)
  • Table 34. Global Human Acellular Vessels (HAVs) Revenue Share by Type (2023-2028)
  • Table 35. Human Acellular Vessels (HAVs) Price by Type (2017-2022) & (US$/Unit)
  • Table 36. Global Human Acellular Vessels (HAVs) Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 37. Global Human Acellular Vessels (HAVs) Sales by Application (2017-2022) & (K Units)
  • Table 38. Global Human Acellular Vessels (HAVs) Sales by Application (2023-2028) & (K Units)
  • Table 39. Global Human Acellular Vessels (HAVs) Sales Share by Application (2017-2022)
  • Table 40. Global Human Acellular Vessels (HAVs) Sales Share by Application (2023-2028)
  • Table 41. Global Human Acellular Vessels (HAVs) Revenue by Application (2017-2022) & (US$ Million)
  • Table 42. Global Human Acellular Vessels (HAVs) Revenue by Application (2023-2028) & (US$ Million)
  • Table 43. Global Human Acellular Vessels (HAVs) Revenue Share by Application (2017-2022)
  • Table 44. Global Human Acellular Vessels (HAVs) Revenue Share by Application (2023-2028)
  • Table 45. Human Acellular Vessels (HAVs) Price by Application (2017-2022) & (US$/Unit)
  • Table 46. Global Human Acellular Vessels (HAVs) Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 47. North America Human Acellular Vessels (HAVs) Sales by Type (2017-2022) & (K Units)
  • Table 48. North America Human Acellular Vessels (HAVs) Sales by Type (2023-2028) & (K Units)
  • Table 49. North America Human Acellular Vessels (HAVs) Revenue by Type (2017-2022) & (US$ Million)
  • Table 50. North America Human Acellular Vessels (HAVs) Revenue by Type (2023-2028) & (US$ Million)
  • Table 51. North America Human Acellular Vessels (HAVs) Sales by Application (2017-2022) & (K Units)
  • Table 52. North America Human Acellular Vessels (HAVs) Sales by Application (2023-2028) & (K Units)
  • Table 53. North America Human Acellular Vessels (HAVs) Revenue by Application (2017-2022) & (US$ Million)
  • Table 54. North America Human Acellular Vessels (HAVs) Revenue by Application (2023-2028) & (US$ Million)
  • Table 55. North America Human Acellular Vessels (HAVs) Sales by Country (2017-2022) & (K Units)
  • Table 56. North America Human Acellular Vessels (HAVs) Sales by Country (2023-2028) & (K Units)
  • Table 57. North America Human Acellular Vessels (HAVs) Revenue by Country (2017-2022) & (US$ Million)
  • Table 58. North America Human Acellular Vessels (HAVs) Revenue by Country (2023-2028) & (US$ Million)
  • Table 59. Europe Human Acellular Vessels (HAVs) Sales by Type (2017-2022) & (K Units)
  • Table 60. Europe Human Acellular Vessels (HAVs) Sales by Type (2023-2028) & (K Units)
  • Table 61. Europe Human Acellular Vessels (HAVs) Revenue by Type (2017-2022) & (US$ Million)
  • Table 62. Europe Human Acellular Vessels (HAVs) Revenue by Type (2023-2028) & (US$ Million)
  • Table 63. Europe Human Acellular Vessels (HAVs) Sales by Application (2017-2022) & (K Units)
  • Table 64. Europe Human Acellular Vessels (HAVs) Sales by Application (2023-2028) & (K Units)
  • Table 65. Europe Human Acellular Vessels (HAVs) Revenue by Application (2017-2022) & (US$ Million)
  • Table 66. Europe Human Acellular Vessels (HAVs) Revenue by Application (2023-2028) & (US$ Million)
  • Table 67. Europe Human Acellular Vessels (HAVs) Sales by Country (2017-2022) & (K Units)
  • Table 68. Europe Human Acellular Vessels (HAVs) Sales by Country (2023-2028) & (K Units)
  • Table 69. Europe Human Acellular Vessels (HAVs) Revenue by Country (2017-2022) & (US$ Million)
  • Table 70. Europe Human Acellular Vessels (HAVs) Revenue by Country (2023-2028) & (US$ Million)
  • Table 71. Asia Pacific Human Acellular Vessels (HAVs) Sales by Type (2017-2022) & (K Units)
  • Table 72. Asia Pacific Human Acellular Vessels (HAVs) Sales by Type (2023-2028) & (K Units)
  • Table 73. Asia Pacific Human Acellular Vessels (HAVs) Revenue by Type (2017-2022) & (US$ Million)
  • Table 74. Asia Pacific Human Acellular Vessels (HAVs) Revenue by Type (2023-2028) & (US$ Million)
  • Table 75. Asia Pacific Human Acellular Vessels (HAVs) Sales by Application (2017-2022) & (K Units)
  • Table 76. Asia Pacific Human Acellular Vessels (HAVs) Sales by Application (2023-2028) & (K Units)
  • Table 77. Asia Pacific Human Acellular Vessels (HAVs) Revenue by Application (2017-2022) & (US$ Million)
  • Table 78. Asia Pacific Human Acellular Vessels (HAVs) Revenue by Application (2023-2028) & (US$ Million)
  • Table 79. Asia Pacific Human Acellular Vessels (HAVs) Sales by Region (2017-2022) & (K Units)
  • Table 80. Asia Pacific Human Acellular Vessels (HAVs) Sales by Region (2023-2028) & (K Units)
  • Table 81. Asia Pacific Human Acellular Vessels (HAVs) Revenue by Region (2017-2022) & (US$ Million)
  • Table 82. Asia Pacific Human Acellular Vessels (HAVs) Revenue by Region (2023-2028) & (US$ Million)
  • Table 83. Latin America Human Acellular Vessels (HAVs) Sales by Type (2017-2022) & (K Units)
  • Table 84. Latin America Human Acellular Vessels (HAVs) Sales by Type (2023-2028) & (K Units)
  • Table 85. Latin America Human Acellular Vessels (HAVs) Revenue by Type (2017-2022) & (US$ Million)
  • Table 86. Latin America Human Acellular Vessels (HAVs) Revenue by Type (2023-2028) & (US$ Million)
  • Table 87. Latin America Human Acellular Vessels (HAVs) Sales by Application (2017-2022) & (K Units)
  • Table 88. Latin America Human Acellular Vessels (HAVs) Sales by Application (2023-2028) & (K Units)
  • Table 89. Latin America Human Acellular Vessels (HAVs) Revenue by Application (2017-2022) & (US$ Million)
  • Table 90. Latin America Human Acellular Vessels (HAVs) Revenue by Application (2023-2028) & (US$ Million)
  • Table 91. Latin America Human Acellular Vessels (HAVs) Sales by Country (2017-2022) & (K Units)
  • Table 92. Latin America Human Acellular Vessels (HAVs) Sales by Country (2023-2028) & (K Units)
  • Table 93. Latin America Human Acellular Vessels (HAVs) Revenue by Country (2017-2022) & (US$ Million)
  • Table 94. Latin America Human Acellular Vessels (HAVs) Revenue by Country (2023-2028) & (US$ Million)
  • Table 95. Middle East and Africa Human Acellular Vessels (HAVs) Sales by Type (2017-2022) & (K Units)
  • Table 96. Middle East and Africa Human Acellular Vessels (HAVs) Sales by Type (2023-2028) & (K Units)
  • Table 97. Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Type (2017-2022) & (US$ Million)
  • Table 98. Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Type (2023-2028) & (US$ Million)
  • Table 99. Middle East and Africa Human Acellular Vessels (HAVs) Sales by Application (2017-2022) & (K Units)
  • Table 100. Middle East and Africa Human Acellular Vessels (HAVs) Sales by Application (2023-2028) & (K Units)
  • Table 101. Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Application (2017-2022) & (US$ Million)
  • Table 102. Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Application (2023-2028) & (US$ Million)
  • Table 103. Middle East and Africa Human Acellular Vessels (HAVs) Sales by Country (2017-2022) & (K Units)
  • Table 104. Middle East and Africa Human Acellular Vessels (HAVs) Sales by Country (2023-2028) & (K Units)
  • Table 105. Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Country (2017-2022) & (US$ Million)
  • Table 106. Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Country (2023-2028) & (US$ Million)
  • Table 107. Getinge Group Corporation Information
  • Table 108. Getinge Group Description and Major Businesses
  • Table 109. Getinge Group Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 110. Getinge Group Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Getinge Group Recent Developments
  • Table 112. Bard Corporation Information
  • Table 113. Bard Description and Major Businesses
  • Table 114. Bard Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 115. Bard Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Bard Recent Developments
  • Table 117. Terumo Corporation Information
  • Table 118. Terumo Description and Major Businesses
  • Table 119. Terumo Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 120. Terumo Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Terumo Recent Developments
  • Table 122. W. L. Gore Corporation Information
  • Table 123. W. L. Gore Description and Major Businesses
  • Table 124. W. L. Gore Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 125. W. L. Gore Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. W. L. Gore Recent Developments
  • Table 127. JUNKEN MEDICAL Corporation Information
  • Table 128. JUNKEN MEDICAL Description and Major Businesses
  • Table 129. JUNKEN MEDICAL Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 130. JUNKEN MEDICAL Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. JUNKEN MEDICAL Recent Developments
  • Table 132. B.Braun Corporation Information
  • Table 133. B.Braun Description and Major Businesses
  • Table 134. B.Braun Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 135. B.Braun Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. B.Braun Recent Developments
  • Table 137. LeMaitre Corporation Information
  • Table 138. LeMaitre Description and Major Businesses
  • Table 139. LeMaitre Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 140. LeMaitre Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. LeMaitre Recent Developments
  • Table 142. Shanghai Suokang Corporation Information
  • Table 143. Shanghai Suokang Description and Major Businesses
  • Table 144. Shanghai Suokang Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 145. Shanghai Suokang Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Shanghai Suokang Recent Developments
  • Table 147. Shanghai Chest Medical Corporation Information
  • Table 148. Shanghai Chest Medical Description and Major Businesses
  • Table 149. Shanghai Chest Medical Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 150. Shanghai Chest Medical Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. Shanghai Chest Medical Recent Developments
  • Table 152. Maquet Corporation Information
  • Table 153. Maquet Description and Major Businesses
  • Table 154. Maquet Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 155. Maquet Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 156. Maquet Recent Developments
  • Table 157. Wuhan Yangsen Corporation Information
  • Table 158. Wuhan Yangsen Description and Major Businesses
  • Table 159. Wuhan Yangsen Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 160. Wuhan Yangsen Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 161. Wuhan Yangsen Recent Developments
  • Table 162. Vascutek Corporation Information
  • Table 163. Vascutek Description and Major Businesses
  • Table 164. Vascutek Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 165. Vascutek Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 166. Vascutek Recent Developments
  • Table 167. Jotec Gmbh Corporation Information
  • Table 168. Jotec Gmbh Description and Major Businesses
  • Table 169. Jotec Gmbh Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 170. Jotec Gmbh Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 171. Jotec Gmbh Recent Developments
  • Table 172. InterVAscular Corporation Information
  • Table 173. InterVAscular Description and Major Businesses
  • Table 174. InterVAscular Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 175. InterVAscular Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 176. InterVAscular Recent Developments
  • Table 177. Atrium Medical Corporation Information
  • Table 178. Atrium Medical Description and Major Businesses
  • Table 179. Atrium Medical Human Acellular Vessels (HAVs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 180. Atrium Medical Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 181. Atrium Medical Recent Developments
  • Table 182. Key Raw Materials Lists
  • Table 183. Raw Materials Key Suppliers Lists
  • Table 184. Human Acellular Vessels (HAVs) Distributors List
  • Table 185. Human Acellular Vessels (HAVs) Customers List
  • Table 186. Human Acellular Vessels (HAVs) Market Trends
  • Table 187. Human Acellular Vessels (HAVs) Market Drivers
  • Table 188. Human Acellular Vessels (HAVs) Market Challenges
  • Table 189. Human Acellular Vessels (HAVs) Market Restraints
  • Table 190. Research Programs/Design for This Report
  • Table 191. Key Data Information from Secondary Sources
  • Table 192. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Human Acellular Vessels (HAVs) Product Picture
  • Figure 3. Global Human Acellular Vessels (HAVs) Market Share by Type in 2021 & 2028
  • Figure 3. ePTFE Vascular Graft Product Picture
  • Figure 4. Polyester Vascular Graft Product Picture
  • Figure 5. PTFE Vascular Graft Product Picture
  • Figure 6. Others Product Picture
  • Figure 7. Global Human Acellular Vessels (HAVs) Market Share by Application in 2021 & 2028
  • Figure 8. Cardiovascular Diseases
  • Figure 9. Aneurysm
  • Figure 10. Vascular Occlusion
  • Figure 11. Others
  • Figure 12. Human Acellular Vessels (HAVs) Report Years Considered
  • Figure 13. Global Human Acellular Vessels (HAVs) Sales 2017-2028 (K Units)
  • Figure 14. Global Human Acellular Vessels (HAVs) Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 15. Global Human Acellular Vessels (HAVs) Revenue 2017-2028 (US$ Million)
  • Figure 16. Global Human Acellular Vessels (HAVs) Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 17. Global Human Acellular Vessels (HAVs) Sales Market Share by Region (2017-2022)
  • Figure 18. Global Human Acellular Vessels (HAVs) Sales Market Share by Region (2023-2028)
  • Figure 19. North America Human Acellular Vessels (HAVs) Sales YoY (2017-2028) & (K Units)
  • Figure 20. North America Human Acellular Vessels (HAVs) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 21. Europe Human Acellular Vessels (HAVs) Sales YoY (2017-2028) & (K Units)
  • Figure 22. Europe Human Acellular Vessels (HAVs) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 23. Asia-Pacific Human Acellular Vessels (HAVs) Sales YoY (2017-2028) & (K Units)
  • Figure 24. Asia-Pacific Human Acellular Vessels (HAVs) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. Latin America Human Acellular Vessels (HAVs) Sales YoY (2017-2028) & (K Units)
  • Figure 26. Latin America Human Acellular Vessels (HAVs) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. Middle East & Africa Human Acellular Vessels (HAVs) Sales YoY (2017-2028) & (K Units)
  • Figure 28. Middle East & Africa Human Acellular Vessels (HAVs) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 29. The Human Acellular Vessels (HAVs) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 30. The Top 5 and 10 Largest Manufacturers of Human Acellular Vessels (HAVs) in the World: Market Share by Human Acellular Vessels (HAVs) Revenue in 2021
  • Figure 31. Global Human Acellular Vessels (HAVs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 32. Global Human Acellular Vessels (HAVs) Sales Market Share by Type (2017-2028)
  • Figure 33. Global Human Acellular Vessels (HAVs) Revenue Market Share by Type (2017-2028)
  • Figure 34. Global Human Acellular Vessels (HAVs) Sales Market Share by Application (2017-2028)
  • Figure 35. Global Human Acellular Vessels (HAVs) Revenue Market Share by Application (2017-2028)
  • Figure 36. North America Human Acellular Vessels (HAVs) Sales Market Share by Type (2017-2028)
  • Figure 37. North America Human Acellular Vessels (HAVs) Revenue Market Share by Type (2017-2028)
  • Figure 38. North America Human Acellular Vessels (HAVs) Sales Market Share by Application (2017-2028)
  • Figure 39. North America Human Acellular Vessels (HAVs) Revenue Market Share by Application (2017-2028)
  • Figure 40. North America Human Acellular Vessels (HAVs) Sales Share by Country (2017-2028)
  • Figure 41. North America Human Acellular Vessels (HAVs) Revenue Share by Country (2017-2028)
  • Figure 42. United States Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 43. Canada Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 44. Europe Human Acellular Vessels (HAVs) Sales Market Share by Type (2017-2028)
  • Figure 45. Europe Human Acellular Vessels (HAVs) Revenue Market Share by Type (2017-2028)
  • Figure 46. Europe Human Acellular Vessels (HAVs) Sales Market Share by Application (2017-2028)
  • Figure 47. Europe Human Acellular Vessels (HAVs) Revenue Market Share by Application (2017-2028)
  • Figure 48. Europe Human Acellular Vessels (HAVs) Sales Share by Country (2017-2028)
  • Figure 49. Europe Human Acellular Vessels (HAVs) Revenue Share by Country (2017-2028)
  • Figure 50. Germany Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 51. France Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 52. U.K. Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 53. Italy Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 54. Russia Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 55. Asia Pacific Human Acellular Vessels (HAVs) Sales Market Share by Type (2017-2028)
  • Figure 56. Asia Pacific Human Acellular Vessels (HAVs) Revenue Market Share by Type (2017-2028)
  • Figure 57. Asia Pacific Human Acellular Vessels (HAVs) Sales Market Share by Application (2017-2028)
  • Figure 58. Asia Pacific Human Acellular Vessels (HAVs) Revenue Market Share by Application (2017-2028)
  • Figure 59. Asia Pacific Human Acellular Vessels (HAVs) Sales Share by Region (2017-2028)
  • Figure 60. Asia Pacific Human Acellular Vessels (HAVs) Revenue Share by Region (2017-2028)
  • Figure 61. China Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 62. Japan Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 63. South Korea Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 64. India Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 65. Australia Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 66. China Taiwan Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 67. Indonesia Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 68. Thailand Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 69. Malaysia Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 70. Latin America Human Acellular Vessels (HAVs) Sales Market Share by Type (2017-2028)
  • Figure 71. Latin America Human Acellular Vessels (HAVs) Revenue Market Share by Type (2017-2028)
  • Figure 72. Latin America Human Acellular Vessels (HAVs) Sales Market Share by Application (2017-2028)
  • Figure 73. Latin America Human Acellular Vessels (HAVs) Revenue Market Share by Application (2017-2028)
  • Figure 74. Latin America Human Acellular Vessels (HAVs) Sales Share by Country (2017-2028)
  • Figure 75. Latin America Human Acellular Vessels (HAVs) Revenue Share by Country (2017-2028)
  • Figure 76. Mexico Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 77. Brazil Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 78. Argentina Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 79. Colombia Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 80. Middle East and Africa Human Acellular Vessels (HAVs) Sales Market Share by Type (2017-2028)
  • Figure 81. Middle East and Africa Human Acellular Vessels (HAVs) Revenue Market Share by Type (2017-2028)
  • Figure 82. Middle East and Africa Human Acellular Vessels (HAVs) Sales Market Share by Application (2017-2028)
  • Figure 83. Middle East and Africa Human Acellular Vessels (HAVs) Revenue Market Share by Application (2017-2028)
  • Figure 84. Middle East and Africa Human Acellular Vessels (HAVs) Sales Share by Country (2017-2028)
  • Figure 85. Middle East and Africa Human Acellular Vessels (HAVs) Revenue Share by Country (2017-2028)
  • Figure 86. Turkey Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 87. Saudi Arabia Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 88. UAE Human Acellular Vessels (HAVs) Revenue (2017-2028) & (US$ Million)
  • Figure 89. Human Acellular Vessels (HAVs) Value Chain
  • Figure 90. Human Acellular Vessels (HAVs) Production Process
  • Figure 91. Channels of Distribution
  • Figure 92. Distributors Profiles
  • Figure 93. Bottom-up and Top-down Approaches for This Report
  • Figure 94. Data Triangulation
  • Figure 95. Key Executives Interviewed
目次

This research report focuses on the Human Acellular Vessels (HAVs) Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Human Acellular Vessels (HAVs) Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Human Acellular Vessels (HAVs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 ePTFE Vascular Graft
    • 1.2.3 Polyester Vascular Graft
    • 1.2.4 PTFE Vascular Graft
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Human Acellular Vessels (HAVs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Cardiovascular Diseases
    • 1.3.3 Aneurysm
    • 1.3.4 Vascular Occlusion
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Human Acellular Vessels (HAVs) Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Human Acellular Vessels (HAVs) Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Human Acellular Vessels (HAVs) Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Human Acellular Vessels (HAVs) Sales by Region
    • 2.4.1 Global Human Acellular Vessels (HAVs) Sales by Region (2017-2022)
    • 2.4.2 Global Sales Human Acellular Vessels (HAVs) by Region (2023-2028)
  • 2.5 Global Human Acellular Vessels (HAVs) Revenue by Region
    • 2.5.1 Global Human Acellular Vessels (HAVs) Revenue by Region (2017-2022)
    • 2.5.2 Global Human Acellular Vessels (HAVs) Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Human Acellular Vessels (HAVs) Sales by Manufacturers
    • 3.1.1 Global Top Human Acellular Vessels (HAVs) Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Human Acellular Vessels (HAVs) Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Acellular Vessels (HAVs) in 2021
  • 3.2 Global Human Acellular Vessels (HAVs) Revenue by Manufacturers
    • 3.2.1 Global Human Acellular Vessels (HAVs) Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Human Acellular Vessels (HAVs) Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Human Acellular Vessels (HAVs) Revenue in 2021
  • 3.3 Global Human Acellular Vessels (HAVs) Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Human Acellular Vessels (HAVs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Human Acellular Vessels (HAVs) Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Human Acellular Vessels (HAVs) Sales by Type
    • 4.1.1 Global Human Acellular Vessels (HAVs) Historical Sales by Type (2017-2022)
    • 4.1.2 Global Human Acellular Vessels (HAVs) Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Human Acellular Vessels (HAVs) Sales Market Share by Type (2017-2028)
  • 4.2 Global Human Acellular Vessels (HAVs) Revenue by Type
    • 4.2.1 Global Human Acellular Vessels (HAVs) Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Human Acellular Vessels (HAVs) Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Human Acellular Vessels (HAVs) Revenue Market Share by Type (2017-2028)
  • 4.3 Global Human Acellular Vessels (HAVs) Price by Type
    • 4.3.1 Global Human Acellular Vessels (HAVs) Price by Type (2017-2022)
    • 4.3.2 Global Human Acellular Vessels (HAVs) Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Human Acellular Vessels (HAVs) Sales by Application
    • 5.1.1 Global Human Acellular Vessels (HAVs) Historical Sales by Application (2017-2022)
    • 5.1.2 Global Human Acellular Vessels (HAVs) Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Human Acellular Vessels (HAVs) Sales Market Share by Application (2017-2028)
  • 5.2 Global Human Acellular Vessels (HAVs) Revenue by Application
    • 5.2.1 Global Human Acellular Vessels (HAVs) Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Human Acellular Vessels (HAVs) Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Human Acellular Vessels (HAVs) Revenue Market Share by Application (2017-2028)
  • 5.3 Global Human Acellular Vessels (HAVs) Price by Application
    • 5.3.1 Global Human Acellular Vessels (HAVs) Price by Application (2017-2022)
    • 5.3.2 Global Human Acellular Vessels (HAVs) Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Human Acellular Vessels (HAVs) Market Size by Type
    • 6.1.1 North America Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
    • 6.1.2 North America Human Acellular Vessels (HAVs) Revenue by Type (2017-2028)
  • 6.2 North America Human Acellular Vessels (HAVs) Market Size by Application
    • 6.2.1 North America Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
    • 6.2.2 North America Human Acellular Vessels (HAVs) Revenue by Application (2017-2028)
  • 6.3 North America Human Acellular Vessels (HAVs) Market Size by Country
    • 6.3.1 North America Human Acellular Vessels (HAVs) Sales by Country (2017-2028)
    • 6.3.2 North America Human Acellular Vessels (HAVs) Revenue by Country (2017-2028)
    • 6.3.3 United States
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Human Acellular Vessels (HAVs) Market Size by Type
    • 7.1.1 Europe Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
    • 7.1.2 Europe Human Acellular Vessels (HAVs) Revenue by Type (2017-2028)
  • 7.2 Europe Human Acellular Vessels (HAVs) Market Size by Application
    • 7.2.1 Europe Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
    • 7.2.2 Europe Human Acellular Vessels (HAVs) Revenue by Application (2017-2028)
  • 7.3 Europe Human Acellular Vessels (HAVs) Market Size by Country
    • 7.3.1 Europe Human Acellular Vessels (HAVs) Sales by Country (2017-2028)
    • 7.3.2 Europe Human Acellular Vessels (HAVs) Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Human Acellular Vessels (HAVs) Market Size by Type
    • 8.1.1 Asia Pacific Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Human Acellular Vessels (HAVs) Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Human Acellular Vessels (HAVs) Market Size by Application
    • 8.2.1 Asia Pacific Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Human Acellular Vessels (HAVs) Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Human Acellular Vessels (HAVs) Market Size by Region
    • 8.3.1 Asia Pacific Human Acellular Vessels (HAVs) Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Human Acellular Vessels (HAVs) Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Human Acellular Vessels (HAVs) Market Size by Type
    • 9.1.1 Latin America Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
    • 9.1.2 Latin America Human Acellular Vessels (HAVs) Revenue by Type (2017-2028)
  • 9.2 Latin America Human Acellular Vessels (HAVs) Market Size by Application
    • 9.2.1 Latin America Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
    • 9.2.2 Latin America Human Acellular Vessels (HAVs) Revenue by Application (2017-2028)
  • 9.3 Latin America Human Acellular Vessels (HAVs) Market Size by Country
    • 9.3.1 Latin America Human Acellular Vessels (HAVs) Sales by Country (2017-2028)
    • 9.3.2 Latin America Human Acellular Vessels (HAVs) Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina
    • 9.3.6 Colombia

10 Middle East and Africa

  • 10.1 Middle East and Africa Human Acellular Vessels (HAVs) Market Size by Type
    • 10.1.1 Middle East and Africa Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Human Acellular Vessels (HAVs) Market Size by Application
    • 10.2.1 Middle East and Africa Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Human Acellular Vessels (HAVs) Market Size by Country
    • 10.3.1 Middle East and Africa Human Acellular Vessels (HAVs) Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Human Acellular Vessels (HAVs) Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Getinge Group
    • 11.1.1 Getinge Group Corporation Information
    • 11.1.2 Getinge Group Overview
    • 11.1.3 Getinge Group Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Getinge Group Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Getinge Group Recent Developments
  • 11.2 Bard
    • 11.2.1 Bard Corporation Information
    • 11.2.2 Bard Overview
    • 11.2.3 Bard Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Bard Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Bard Recent Developments
  • 11.3 Terumo
    • 11.3.1 Terumo Corporation Information
    • 11.3.2 Terumo Overview
    • 11.3.3 Terumo Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Terumo Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Terumo Recent Developments
  • 11.4 W. L. Gore
    • 11.4.1 W. L. Gore Corporation Information
    • 11.4.2 W. L. Gore Overview
    • 11.4.3 W. L. Gore Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 W. L. Gore Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 W. L. Gore Recent Developments
  • 11.5 JUNKEN MEDICAL
    • 11.5.1 JUNKEN MEDICAL Corporation Information
    • 11.5.2 JUNKEN MEDICAL Overview
    • 11.5.3 JUNKEN MEDICAL Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 JUNKEN MEDICAL Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 JUNKEN MEDICAL Recent Developments
  • 11.6 B.Braun
    • 11.6.1 B.Braun Corporation Information
    • 11.6.2 B.Braun Overview
    • 11.6.3 B.Braun Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 B.Braun Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 B.Braun Recent Developments
  • 11.7 LeMaitre
    • 11.7.1 LeMaitre Corporation Information
    • 11.7.2 LeMaitre Overview
    • 11.7.3 LeMaitre Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 LeMaitre Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 LeMaitre Recent Developments
  • 11.8 Shanghai Suokang
    • 11.8.1 Shanghai Suokang Corporation Information
    • 11.8.2 Shanghai Suokang Overview
    • 11.8.3 Shanghai Suokang Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Shanghai Suokang Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Shanghai Suokang Recent Developments
  • 11.9 Shanghai Chest Medical
    • 11.9.1 Shanghai Chest Medical Corporation Information
    • 11.9.2 Shanghai Chest Medical Overview
    • 11.9.3 Shanghai Chest Medical Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Shanghai Chest Medical Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Shanghai Chest Medical Recent Developments
  • 11.10 Maquet
    • 11.10.1 Maquet Corporation Information
    • 11.10.2 Maquet Overview
    • 11.10.3 Maquet Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Maquet Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Maquet Recent Developments
  • 11.11 Wuhan Yangsen
    • 11.11.1 Wuhan Yangsen Corporation Information
    • 11.11.2 Wuhan Yangsen Overview
    • 11.11.3 Wuhan Yangsen Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 Wuhan Yangsen Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Wuhan Yangsen Recent Developments
  • 11.12 Vascutek
    • 11.12.1 Vascutek Corporation Information
    • 11.12.2 Vascutek Overview
    • 11.12.3 Vascutek Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Vascutek Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Vascutek Recent Developments
  • 11.13 Jotec Gmbh
    • 11.13.1 Jotec Gmbh Corporation Information
    • 11.13.2 Jotec Gmbh Overview
    • 11.13.3 Jotec Gmbh Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.13.4 Jotec Gmbh Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Jotec Gmbh Recent Developments
  • 11.14 InterVAscular
    • 11.14.1 InterVAscular Corporation Information
    • 11.14.2 InterVAscular Overview
    • 11.14.3 InterVAscular Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.14.4 InterVAscular Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 InterVAscular Recent Developments
  • 11.15 Atrium Medical
    • 11.15.1 Atrium Medical Corporation Information
    • 11.15.2 Atrium Medical Overview
    • 11.15.3 Atrium Medical Human Acellular Vessels (HAVs) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.15.4 Atrium Medical Human Acellular Vessels (HAVs) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Atrium Medical Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Human Acellular Vessels (HAVs) Industry Chain Analysis
  • 12.2 Human Acellular Vessels (HAVs) Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Human Acellular Vessels (HAVs) Production Mode & Process
  • 12.4 Human Acellular Vessels (HAVs) Sales and Marketing
    • 12.4.1 Human Acellular Vessels (HAVs) Sales Channels
    • 12.4.2 Human Acellular Vessels (HAVs) Distributors
  • 12.5 Human Acellular Vessels (HAVs) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Human Acellular Vessels (HAVs) Industry Trends
  • 13.2 Human Acellular Vessels (HAVs) Market Drivers
  • 13.3 Human Acellular Vessels (HAVs) Market Challenges
  • 13.4 Human Acellular Vessels (HAVs) Market Restraints

14 Key Findings in The Global Human Acellular Vessels (HAVs) Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer